BioSpace News Archive

Policy

Science Has a Sexual Harassment Problem – Here’s What’s Being Done About it

Sexual harassment has been a big focus in the news as of late, but much of this focus has been primarily concerned with the harassment issues in Hollywood and the political sphere. However, the scientific community has long been criticized for being a hostile environment for women as well.

October 4, 2018
·
3 min read
·
Sasha Mortimer
FDA

Genentech’s Hemlibra Approved for Hemophilia A Patients Without Factor VIII Inhibitors

Genentech snagged a new regulatory approval for its hemophilia treatment, Hemlibra. On Thursday the U.S. Food and Drug Administration approved the medication for hemophilia A patients who do not have factor VIII inhibitors.

October 4, 2018
·
2 min read
·
Alex Keown
Business

Boehringer and Lilly’s Jardiance Looks Good for Type I Diabetes

Boehringer Ingelheim and Eli Lilly released data from their Empagliflozin as Adjunctive to inSulin thErapy (EASE) Phase III trial in type 1 diabetes.

October 4, 2018
·
3 min read
·
Mark Terry
Business

Arrowhead Goes All in With J&J to Develop Hep B Drug for $3.7B

Arrowhead announced a deal with Johnson & Johnson that could conceivably be worth over $3.7 billion, with J&J agreeing to pick up a minor stake in the company, including the task of cultivating and promoting its ARO-HBV Hepatitis B drug.

October 4, 2018
·
3 min read
·
Elizabeth Glasure
Business

Leading Pharma Executive Kate Hilyard Joins Healx to Drive the Integration of AI with Drug Discovery for Rare Diseases

Healx today announced the appointment of Kate Hilyard PhD as Chief Operating Officer (COO).

October 4, 2018
·
4 min read
Business

Rewind Therapeutics appoints leading neuroscience drug developer Ian J. Reynolds as Chief Executive Officer

Rewind Therapeutics announces the appointment of Ian J. Reynolds as its Chief Executive Officer (CEO).

October 4, 2018
·
3 min read
Business

Ingenza extends successful collaboration with Syngenta

Ingenza has announced that its collaboration with Syngenta for work on efficient technologies to support the development of crop protection products has been extended.

October 4, 2018
·
2 min read
Drug Development

October 5 Research Roundup: HIV, the Microbiome and Cancer, and Fruits & Veggies

There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.

October 4, 2018
·
6 min read
·
Mark Terry
Bosses, Managers, and Leaders: Is Your Inbox Preventing You From Doing Your Job?

Email is an inescapable form of communication that informs nearly every single aspect of our lives, from personal to professional. But what happens when your inbox starts to work against you?

October 4, 2018
·
3 min read
·
Editorial Staff
Drug Development

It’s Flu Season! Genentech’s Investigational Medicine Continues to Show Efficacy

New late-stage data released by South San Francisco-based Genentech shows treatment with baloxavir marboxil significantly reduced the time to improvement of influenza symptoms versus placebo in patients who are at high risk of serious complications from the flu.

October 4, 2018
·
2 min read
·
Alex Keown